Literature DB >> 20530665

The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.

Cullen M Taniguchi1, Jonathon Winnay, Tatsuya Kondo, Roderick T Bronson, Alexander R Guimaraes, José O Alemán, Ji Luo, Gregory Stephanopoulos, Ralph Weissleder, Lewis C Cantley, C Ronald Kahn.   

Abstract

Phosphoinositide 3-kinase (PI3K) plays a critical role in tumorigenesis, and the PI3K p85 regulatory subunit exerts both positive and negative effects on signaling. Expression of Pik3r1, the gene encoding p85, is decreased in human prostate, lung, ovarian, bladder, and liver cancers, consistent with the possibility that p85 has tumor suppressor properties. We tested this hypothesis by studying mice with a liver-specific deletion of the Pik3r1 gene. These mice exhibited enhanced insulin and growth factor signaling and progressive changes in hepatic pathology, leading to the development of aggressive hepatocellular carcinomas with pulmonary metastases. Liver tumors that arose exhibited markedly elevated levels of phosphatidylinositol (3,4,5)-trisphosphate, along with Akt activation and decreased PTEN expression, at both the mRNA and protein levels. Together, these results substantiate the concept that the p85 subunit of PI3K has a tumor-suppressive role in the liver and possibly other tissues. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530665      PMCID: PMC3204358          DOI: 10.1158/0008-5472.CAN-09-3399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  The life and death of DNA-PK.

Authors:  Spencer J Collis; Theodore L DeWeese; Penelope A Jeggo; Antony R Parker
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

Review 2.  Dysregulation of growth factor signaling in human hepatocellular carcinoma.

Authors:  K Breuhahn; T Longerich; P Schirmacher
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

Review 3.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

4.  Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.

Authors:  Kohjiro Ueki; Claudine M Yballe; Saskia M Brachmann; David Vicent; John M Watt; C Ronald Kahn; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.

Authors:  J Gotzmann; A N M Fischer; M Zojer; M Mikula; V Proell; H Huber; M Jechlinger; T Waerner; A Weith; H Beug; W Mikulits
Journal:  Oncogene       Date:  2006-05-25       Impact factor: 9.867

6.  Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.

Authors:  Robert S Stearman; Lori Dwyer-Nield; Laura Zerbe; Stacy A Blaine; Zeng Chan; Paul A Bunn; Gary L Johnson; Fred R Hirsch; Daniel T Merrick; Wilbur A Franklin; Anna E Baron; Robert L Keith; Raphael A Nemenoff; Alvin M Malkinson; Mark W Geraci
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 7.  Understanding PTEN regulation: PIP2, polarity and protein stability.

Authors:  N R Leslie; I H Batty; H Maccario; L Davidson; C P Downes
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

8.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

Authors:  Jacques Lapointe; Chunde Li; John P Higgins; Matt van de Rijn; Eric Bair; Kelli Montgomery; Michelle Ferrari; Lars Egevad; Walter Rayford; Ulf Bergerheim; Peter Ekman; Angelo M DeMarzo; Robert Tibshirani; David Botstein; Patrick O Brown; James D Brooks; Jonathan R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-07       Impact factor: 11.205

9.  X chromosomal abnormalities in basal-like human breast cancer.

Authors:  Andrea L Richardson; Zhigang C Wang; Arcangela De Nicolo; Xin Lu; Myles Brown; Alexander Miron; Xiaodong Liao; J Dirk Iglehart; David M Livingston; Shridar Ganesan
Journal:  Cancer Cell       Date:  2006-02       Impact factor: 31.743

Review 10.  Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk.

Authors:  Li Li; Sarah J Plummer; Cheryl L Thompson; Thomas C Tucker; Graham Casey
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

View more
  78 in total

Review 1.  Coordination between RAB GTPase and phosphoinositide regulation and functions.

Authors:  Steve Jean; Amy A Kiger
Journal:  Nat Rev Mol Cell Biol       Date:  2012-06-22       Impact factor: 94.444

2.  PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.

Authors:  Lauren M Thorpe; Jennifer M Spangle; Carolynn E Ohlson; Hailing Cheng; Thomas M Roberts; Lewis C Cantley; Jean J Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

3.  Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.

Authors:  Vicente Pérez-García; Javier Redondo-Muñoz; Amit Kumar; Ana C Carrera
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

4.  p85α is a microRNA target and affects chemosensitivity in pancreatic cancer.

Authors:  Paul A Toste; Luyi Li; Brian E Kadera; Andrew H Nguyen; Linh M Tran; Nanping Wu; David L Madnick; Sanjeet G Patel; David W Dawson; Timothy R Donahue
Journal:  J Surg Res       Date:  2015-03-06       Impact factor: 2.192

5.  Class IA PI3K p110β subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation.

Authors:  Zhixun Dou; Ji-An Pan; Hashem A Dbouk; Lisa M Ballou; Jennifer L DeLeon; Yongjun Fan; Juei-Suei Chen; Zhimin Liang; Guangpu Li; Jonathan M Backer; Richard Z Lin; Wei-Xing Zong
Journal:  Mol Cell       Date:  2013-02-21       Impact factor: 17.970

Review 6.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

7.  Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.

Authors:  Carlo Schneider; Andreas Teufel; Tetyana Yevsa; Frank Staib; Anja Hohmeyer; Gudrun Walenda; Henning W Zimmermann; Mihael Vucur; Sebastian Huss; Nikolaus Gassler; Hermann E Wasmuth; Sergio A Lira; Lars Zender; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

8.  High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.

Authors:  Lydia W T Cheung; Bryan T Hennessy; Jie Li; Shuangxing Yu; Andrea P Myers; Bojana Djordjevic; Yiling Lu; Katherine Stemke-Hale; Mary D Dyer; Fan Zhang; Zhenlin Ju; Lewis C Cantley; Steven E Scherer; Han Liang; Karen H Lu; Russell R Broaddus; Gordon B Mills
Journal:  Cancer Discov       Date:  2011-06-07       Impact factor: 39.397

Review 9.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

10.  BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.

Authors:  Yu-Hsin Chiu; Jennifer Y Lee; Lewis C Cantley
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.